share_log

Bristol-Myers Squibb | 4: Statement of changes in beneficial ownership of securities-Director YALE PHYLLIS R

Bristol-Myers Squibb | 4: Statement of changes in beneficial ownership of securities

施貴寶 | 4:持股變動聲明
SEC announcement ·  04/02 18:46
Moomoo AI 已提取核心訊息
Phyllis R. Yale, a reporting person for Bristol-Myers Squibb Co. [BMY], has engaged in a transaction involving the company's stock on March 31, 2024. The details of the transaction, including the number of shares, nature of the shares, transaction price, and the total value of shares, have not been disclosed in the announcement. The relationship of Yale to the issuer was not specified, and the transaction's status, whether it was a purchase or sale, is also not provided in the available information.
Phyllis R. Yale, a reporting person for Bristol-Myers Squibb Co. [BMY], has engaged in a transaction involving the company's stock on March 31, 2024. The details of the transaction, including the number of shares, nature of the shares, transaction price, and the total value of shares, have not been disclosed in the announcement. The relationship of Yale to the issuer was not specified, and the transaction's status, whether it was a purchase or sale, is also not provided in the available information.
菲利斯·耶魯,百時美施貴寶公司的舉報人[BMY] 於2024年3月31日進行了一筆涉及公司股票的交易。該交易的細節,包括股票數量、股票性質、交易價格和股票總價值,尚未在公告中披露。沒有具體說明耶魯與發行人的關係,現有信息中也沒有提供該交易的狀態,無論是買入還是出售。
菲利斯·耶魯,百時美施貴寶公司的舉報人[BMY] 於2024年3月31日進行了一筆涉及公司股票的交易。該交易的細節,包括股票數量、股票性質、交易價格和股票總價值,尚未在公告中披露。沒有具體說明耶魯與發行人的關係,現有信息中也沒有提供該交易的狀態,無論是買入還是出售。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息